FDA Inspection 875388 — Jiangsu Puxin Pharmaceuticals Development Co. Ltd
The FDA completed an inspection of Jiangsu Puxin Pharmaceuticals Development Co. Ltd on Mar 28, 2014 in Yancheng. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 28, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Yancheng (China)